[1]. M. Abdel-Tawab, H. Zettl, M. Schubert-Zsilavecz, Nonsteroidal anti-inflammatory drugs: a critical review on current concepts applied to reduce gastrointestinal toxicity,
Current Medicinal Chemistry,
2009,
16, 2042-2063. [
Crossref], [
Google Scholar], [
Publisher]
[2]. H.A. Al-Haboubi, I.J. Zeitlin, Re-appraisal of the role of histamine in carrageenan-induced paw oedema,
European Journal of Pharmacology,
1983,
88, 169-176. [
Crossref], [
Google Scholar], [
Publisher]
[3]. A. Almasirad, M. Tajik, D. Bakhtiari, A. Shafiee, M. Abdollahi, M.J. Zamani, R. Khorasani, H. Esmaily, Synthesis and analgesic activity of
N-arylhydrazone derivatives of mefenamic acid,
Journal of Pharmaceutical Sciences,
2005,
8, 419-425. [
Crossref], [
Google Scholar]
[4]. A. Almasirad, A. Shafiee, M. Abdollahi, A. Noeparast, N. Shahrokhinejad, N. Vousooghi, S.A. Tabatabai, R. Khorasani, Synthesis and analgesic activity of new 1, 3, 4-oxadiazoles and 1, 2, 4-triazoles,
Medicinal Chemistry Research,
2011,
20, 435-442. [
Crossref], [
Google Scholar], [
Publisher]
[5]. G. Sharma, S.B. Sharma, Synthetic Impatienol analogues as potential cyclooxygenase-2 inhibitors: A preliminary study,
Journal of Applied Organometallic Chemistry,
2021,
1, 66-75. [
Crossref], [
Google Scholar], [
Publisher]
[6]. A. Almasirad, S. Samiee-Sadr, A. Shafiee, Synthesis and antimycobacterial activity of 2-(Phenylthio) benzoylarylhydrazone derivatives,
Iranian Journal of Pharmaceutical Research,
2011,
10, 727-731. [
Google Scholar], [
Publisher]
[7]. A. Almasirad, Z. Mousavi, M. Tajik, M.J. Assarzadeh, A. Shafiee, Synthesis, analgesic and anti-inflammatory activities of new methyl-imidazolyl-1, 3, 4-oxadiazoles and 1, 2, 4-triazoles,
Daru Journal of Pharmaceutical Sciences,
2014,
22, 1-8. [
Crossref], [
Google Scholar], [
Publisher]
[8]. A. Almasirad, P.S.V. Sani, Z. Mousavi, G.B. Fard, T. Anvari, M. Farhadi, M. Vosooghi, H. Azizian, Novel thiazolotriazolone derivatives: design, synthesis, in silico investigation, analgesic and anti‐inflammatory activity,
Chemistry Select,
2022,
7, e202103228. [
Crossref], [
Google Scholar], [
Publisher]
[9]. M. Amir, S.A. Javed, H. Kumar, Design and synthesis of 3-[3-(substituted phenyl)-4-piperidin-1-ylmethyl/-4-morpholin-4-ylmethyl-4, 5-dihydro-isoxazol-5-yl]-1
H-indoles as potent anti-inflammatory agents,
Medicinal Chemistry Research,
2010,
19, 299-310. [
Crossref], [
Google Scholar], [
Publisher]
[10]. S. Bindu, S. Mazumder, U. Bandyopadhyay, Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective,
Biochemical Pharmacology, 2020,
180, 114147. [
Crossref], [
Google Scholar], [
Publisher]
[11]. A.M. Brown, A new software for carrying out one-way ANOVA post hoc tests,
Computer Methods and Programs in Biomedicine,
2005,
79, 89-95. [
Crossref], [
Google Scholar], [
Publisher]
[12]. V. Cioli, S. Putzolu, V. Rossi, P.S. Barcellona, C. Corradino, The role of direct tissue contact in the production of gastrointestinal ulcers by anti-inflammatory drugs in rats,
Toxicology and Applied Pharmacology,
1979,
50, 283-289. [
Crossref], [
Google Scholar], [
Publisher]
[13]. M. Fernández, J. Caballero, QSAR modeling of matrix metalloproteinase inhibition by
N- hydroxy-
α-phenylsulfonylacetamide derivatives,
Bioorganic & Medicinal Chemistry,
2007,
15, 6298-6310. [
Crossref], [
Google Scholar], [
Publisher]
[14]. J.M. Figueiredo, C. de A Câmara, E.G. Amarante, A.L.P. Miranda, F.M. Santos, C.R. Rodrigues, C.A.M. Fraga, E.J. Barreiro, Design and synthesis of novel potent antinociceptive agents: methyl-imidazolyl
N-acylhydrazone derivatives,
Bioorganic & Medicinal Chemistry,
2000,
8, 2243-2248. [
Crossref], [
Google Scholar], [
Publisher]
[15]. L.C. Gerstenfeld, M. Thiede, K. Seibert, C. Mielke, D. Phippard, B. Svagr, D. Cullinane, T.A. Einhorn, Differential inhibition of fracture healing by non‐selective and cyclooxygenase‐2 selective non‐steroidal anti‐inflammatory drugs,
Journal of Orthopaedic Research,
2003,
21, 670-675. [
Crossref], [
Google Scholar], [
Publisher]
[16]. A.A. Geronikaki, A.A. Lagunin, D.I. Hadjipavlou-Litina, P.T. Eleftheriou, D.A. Filimonov, V.V. Poroikov, I. Alam, A.K. Saxena, Computer-aided discovery of anti-inflammatory thiazolidinones with dual cyclooxygenase/lipoxygenase inhibition,
Journal of Medicinal Chemistry,
2008,
51, 1601-1609. [
Crossref], [
Google Scholar], [
Publisher]
[17]. M.M. Hanna, New pyrimido [5, 4-e] pyrrolo [1, 2-c] pyrimidines: Synthesis, 2D-QSAR, anti-inflammatory, analgesic and ulcerogenicity studies,
European Journal of Medicinal Chemistry,
2012,
55, 12-22. [
Crossref], [
Google Scholar], [
Publisher]
[18]. D. Kadam, S. Patil, D. Mammen, S. Kadam, V. More, In silico molecular docking against-KIT Tyrosine Kinase and ADME studies of 4-thiazolidinone derivatives,
Journal of Applied Organometallic Chemistry,
2023,
3, 13-27. [
Crossref], [
Google Scholar], [
Publisher]
[19]. M.N. Koopaei, M.J. Assarzadeh, A. Almasirad, S.F. Ghasemi-Niri, M. Amini, A. Kebriaeezadeh, N.N. Koopaei, M. Ghadimi, A. Tabei, Synthesis and analgesic activity of novel hydrazide and hydrazine derivatives,
Iranian Journal of Pharmaceutical Research,
2013,
12, 721-727. [Crossref], [
Google Scholar], [
Publisher]
[20]. M. Khoshneviszadeh, N. Edraki, R. Miri, B. Hemmateenejad, Exploring QSAR for substituted 2‐sulfonyl‐phenyl‐indol derivatives as potent and selective COX‐2 inhibitors using different chemometrics tools,
Chemical Biology & Drug Design,
2008,
72, 564-574. [
Crossref], [
Google Scholar], [
Publisher]
[21]. S.H.E. Ketabforoosh, M. Amini, M. Vosooghi, A. Shafiee, E. Azizi, F. Kobarfard, Synthesis, evaluation of anticancer activity and QSAR study of heterocyclic esters of caffeic acid,
Iranian Journal of Pharmaceutical Research,
2013,
12, 705. [
Google Scholar], [
Publisher]
[22]. D. Laxmi, S. Priyadarshy, HyperChem 6.03,
Biotech Software & Internet Report: The Computer Software Journal for Scientists,
2002,
3, 5-9. [
Crossref], [
Google Scholar], [
Publisher]
[23]. K. Meirer, D. Steinhilber, E. Proschak, Inhibitors of the arachidonic acid cascade: interfering with multiple pathways,
Basic & Clinical Pharmacology & Toxicology,
2014,
114, 83-91. [
Crossref], [
Google Scholar], [
Publisher]
[24]. M. Mahboubi-Rabbani, A. Zarghi, Dual human carbonic anhydrase/cyclooxygenase-2 inhibitors: A promising approach for cancer treatment,
Anti-Cancer Agents in Medicinal Chemistry,
2021,
21, 2163-2180. [
Crossref], [
Google Scholar], [
Publisher]
[25]. M. Mahboubi-Rabbani, M. Abbasi, A. Zarghi, Natural-derived COX-2 inhibitors as anticancer drugs: A review of their structural diversity and mechanism of action,
Anti-Cancer Agents in Medicinal Chemistry,
2023,
23, 15-36. [
Crossref], [
Google Scholar], [
Publisher]
[26]. M. Mahboubi-Rabbani, A. Zarghi, Selective COX-2 inhibitors as anticancer agents: A patent review (2014-2018),
Expert Opinion on Therapeutic Patents,
2019,
29, 1-21. [
Crossref], [
Google Scholar], [
Publisher]
[27]. M. Mahboubi-Rabbani, A. Zarghi, Lipoxygenase inhibitors as cancer chemopreventives: Discovery, recent developments and future perspectives,
Current Medicinal Chemistry,
2021,
28, 1143-1175. [
Crossref], [
Google Scholar], [
Publisher]
[28]. G.M. Morris, D.S. Goodsell, R.S. Halliday, R. Huey, W.E. Hart, R.K. Belew, A.J. Olson, Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function,
Journal of Computational Chemistry,
1998,
19, 1639-1662. [
Crossref], [
Google Scholar], [
Publisher]
[29]. T. Previtera, M. Vigorita, M. Basile, G. Fenech, A. Trovato, F. Occhiuto, M. Monforte, R. Barbera, 3, 3′-di (1, 3-thiazolidine-4-one) system. V. Synthesis and pharmacological properties of 3, 3′(1, 2-ethanediyl)
bis-(2-heteroaryl-1, 3-thiazolidine-4-one) derivatives,
European Journal of Medicinal Chemistry,
1990,
25, 569-579. [
Crossref], [
Google Scholar], [
Publisher]
[30]. H. Al-Madhagi, Empowering therapeutic strategies against methicillin-resistant staphylococcus aureus riboswitch: Unveiling the potential of small molecules and antisense oligonucleotides through in silico analysis,
Advanced Journal of Chemistry, Section A, 2024,
7, 15-26. [
Crossref], [
Google Scholar], [
Publisher]
[31]. A.A. Rad, M. Sheikhha, R. Hosseini, S.A. Tabatabaic, A. Shafiee, Synthesis and Morphine Enhancement Activity of
N‐[5‐(2‐phenoxyphenyl)‐1, 3, 4‐oxadiazole‐2‐yl]‐
N′‐phenylurea derivatives,
Archiv der Pharmazie: An International Journal Pharmaceutical and Medicinal Chemistry,
2004,
337, 193-200. [
Crossref], [
Google Scholar], [
Publisher]
[32]. L.S. Simon, Role and regulation of cyclooxygenase-2 during inflammation,
The American Journal of Medicine,
1999,
106, 37S-42S. [
Crossref], [
Google Scholar], [
Publisher]
[33]. R. Todeschini, P. Gramatica, The WHIM theory: New 3D molecular descriptors for QSAR in environmental modelling,
SAR and QSAR in Environmental Research,
1997,
7, 89-115. [
Crossref], [
Google Scholar], [
Publisher]
[34]. R. Todeschini, P. Gramatica, SD‐modelling and prediction by WHIM descriptors. Part 5. Theory development and chemical meaning of WHIM descriptors,
Quantitative Structure‐Activity Relationships,
1997,
16, 113-119. [
Crossref], [
Google Scholar], [
Publisher]
[35]. A. John, A. Ebune, I. Aderemi, A. Moyosore, G. Idah, Theoretical investigation and design of novel anti-proliferative agents against hepatocellular carcinoma from benzimidazole-chalcone derivatives,
Advanced Journal of Chemistry, Section A, 2023,
6, 92-104. [
Crossref], [
Google Scholar], [
Publisher]
[36]. K. Aminu, A. Uzairu, S. Abechi, G. Adamu, A. Umar, A search for novel antidiabetic agents using ligand-based drug design and molecular docking studies employing human intestinal maltase-glucoamylase as model enzyme,
Advanced Journal of Chemistry, Section A,
2023,
6, 155-171. [
Crossref], [
Google Scholar], [
Publisher]
[37]. O. Trott, A.J. Olson, AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading,
Journal of Computational Chemistry,
2010,
31, 455-461. [
Crossref], [
Google Scholar], [
Publisher]
[38]. M. Vigorita, R. Ottanà, F. Monforte, R. Maccari, M. Monforte, A. Trovato, M. Taviano, N. Miceli, G. De Luca, S. Alcaro, Chiral 3, 3′-(1, 2-ethanediyl)-
bis [2-(3, 4-dimethoxyphenyl)-4-thiazolidinones] with anti-inflammatory activity. Part 11: Evaluation of COX-2 selectivity and modelling,
Bioorganic & Medicinal Chemistry,
2003,
11, 999-1006. [
Crossref], [
Google Scholar], [
Publisher]
[39]. F. Ugbe, G. Shallangwa, A. Uzairu, I. Abdulkadir, A 2-D QSAR modeling, molecular docking study and design of 2-arylbenzimidazole derivatives as novel leishmania inhibitors: A molecular dynamics study,
Advanced Journal of Chemistry, Section A,
2023,
6, 50-64. [
Crossref], [
Google Scholar], [
Publisher]
[40]. A. Verma, S.K. Saraf, 4-Thiazolidinone–A biologically active scaffold,
European Journal of Medicinal Chemistry,
2008,
43, 897-905. [
Crossref], [
Google Scholar], [
Publisher]
[41]. J.L. Wallace, Distribution and expression of cyclooxygenase (COX) isoenzymes, their physiological roles, and the categorization of nonsteroidal anti-inflammatory drugs (NSAIDs),
The American Journal of Medicine,
1999,
107, 11-16. [
Crossref], [
Google Scholar], [
Publisher]
[42]. B. Whittle, The use of changes in capillary permeability in mice to distinguish between narcotic and nonnarcotic analgesics,
British Journal of Pharmacology and Chemotherapy,
1964,
22, 246-253. [
Crossref], [
Google Scholar], [
Publisher]